Skip to content

NextCure, Inc.

NXTC

CIK 0001661059

← back to feed
Revenue (TTM)
$26.72M
+252.6% YoY Q1 May 2026
Net Income (TTM)
−$56.2M
−0.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$21.08
+17.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-216.9%
Q1 May 2026
Net Margin
-210.3%
Q1 May 2026
Free Cash Flow (TTM)
−$55.1M
Q1 May 2026
Cash
$15.17M
Q1 May 2026
Total Debt
$2.64M
Q1 May 2026
Shares Outstanding
3.61M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings